Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Allergic contact dermatitis: how to re-induce tolerance?].

Marc Vocanson1, Anca Hennino, Cyril Chavagnac

  • 1Inserm U.503 et U.404, IFR 128 BioSciences Lyon-Gerland, 21, avenue Tony Garnier, 69375 Lyon Cedex 7, France.

Medecine Sciences : M/S
|February 7, 2006
PubMed
Summary

Allergic contact dermatitis (ACD) involves a breakdown of immune tolerance. Regulatory CD4+ T cells (Treg) normally prevent skin inflammation and eczema by producing IL-10 and TGF-beta, offering new treatment targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From legacy subsets to auditable descriptors: implementing the 2025 T-cell nomenclature guidelines for inflammatory skin diseases.

The British journal of dermatology·2026
Same author

Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cells.

Journal for immunotherapy of cancer·2026
Same author

Hailey-Hailey disease exhibits a mixed type 2/type 3 molecular signature but shows a therapeutic response to type 2 inhibitors.

European journal of dermatology : EJD·2026
Same author

Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema.

Allergy·2026
Same author

Interpreting assay sensitivity and population selection in paediatric alopecia areata trials: letter in reply.

The British journal of dermatology·2026
Same author

Atopic Dermatitis-like mouse model using early inoculation of patient-derived <i>S. aureus</i> together with MC903.

JID innovations : skin science from molecules to population health·2026

Area of Science:

  • Immunology
  • Dermatology

Background:

  • Allergic contact dermatitis (ACD) is a T-cell mediated skin inflammation triggered by haptens.
  • CD4+ T cells play a crucial role in immune tolerance and regulation of skin inflammation.
  • ACD signifies a failure of immune tolerance to skin-contacting haptens.

Purpose of the Study:

  • To explore the regulatory and tolerogenic functions of CD4+ T cells in ACD.
  • To investigate the role of regulatory T cell subsets (Treg) and their cytokines in maintaining tolerance.
  • To review current and future strategies for re-inducing hapten-specific immune tolerance in ACD.

Main Methods:

  • Review of immunological mechanisms in ACD.
  • Analysis of the function of CD4+CD25+ natural Treg cells and their immunosuppressive cytokines (IL-10, TGF-beta).

Related Experiment Videos

  • Examination of existing and novel tolerance induction methods.

    • Main Results:

    • CD4+ T cells, particularly natural Treg cells, are essential for immune tolerance to haptens.
    • These Treg cells suppress inflammation and prevent eczema through IL-10 and TGF-beta production.
    • Breakdown of this Treg function leads to ACD.

    Conclusions:

    • Restoring immune tolerance is key to treating ACD and related allergic diseases.
    • Strategies like enhancing Treg cell activity and cytokine production offer therapeutic potential.
    • Further research into tolerance induction could lead to new treatments for eczema and autoimmune disorders.